# FDA Inspection 1063039 - HomeChoice Partners dba BioScript Infusion Services - August 17, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/homechoice-partners-dba-bioscript-infusion-services/b167f834-d345-4fa2-8d54-b63f004a7e30/
Source feed: FDA_Inspections

> FDA Inspection 1063039 for HomeChoice Partners dba BioScript Infusion Services on August 17, 2018. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1063039
- Company Name: HomeChoice Partners dba BioScript Infusion Services
- Inspection Date: 2018-08-17
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1149010 - 2021-08-09](https://www.globalkeysolutions.net/api/records/fda_inspections/homechoice-partners-dba-bioscript-infusion-services/46c0708b-268c-4a42-b981-2410f5dbb266/)

Company: https://www.globalkeysolutions.net/companies/homechoice-partners-dba-bioscript-infusion-services/2033b1d3-4a0c-4ca0-ace7-71940400400c

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c